Abstract
The aim of this study was to evaluate the quality of long-term cryopreserved umbilical cord blood (CB) units for hematopoietic cell transplantation (HCT). The recovery of the number of total nucleated cell (TNC), hematopoietic progenitor cells (HPCs; CD34+ cells, colony-forming units-granulocyte/macrophages [CFU-GMs]), and the percentage of viable cells, CD34+ CD38− cells, and CD34+ CXCR4+ cells of CB units cryopreserved for 10 years for HCT were examined. Eighteen CB units cryopreserved for 10 years (as the study group) and for 1 month (as the control group), respectively, were analyzed. The recovery rate of TNC, CD34+ cells and CFU-GMs were 88.72 ± 16.40, 68.39 ± 18.37 and 42.28 ± 38.16% for the study group and 80.17 ± 14.46, 72.67 ± 20.38 and 49.61 ± 36.39% for the control group (p = 0.106, p = 0.513 and p = 0.559, respectively). There were no significant differences in the recovery rate of TNC, CD34+ cells and CFU-GMs between the study group and the control group. The mean basal percentage of viable cells, CD34+ CD38− cells, and CD34+ CXCR4+ cells after thawing were 83.69 ± 9.45, 9.11 ± 4.13 and 81.65 ± 10.82% for the study group. These results indicate that long-term cryopreservation does not negatively affect the quality of CB units for HCT.
Similar content being viewed by others
References
Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 2002;100:1611–8.
Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med. 2004;351:2265–75.
Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004;351:2276–85.
Laroche V, McKenna DH, Moroff G, Schierman T, Kadidlo D, McCullough J. Cell loss and recovery in umbilical cord blood processing: a comparison of postthaw and postwash samples. Transfusion. 2005;45:1909–16.
Timeus F, Crescenzio N, Saracco P, Doria A, Fazio L, Albiani R, et al. Recovery of cord bloos hematopoietic progenitors after successive freezing and thawing procedures. Haematologica. 2003;88:74–9.
Solves P, Mirabet V, Planelles D, Carbonell-Uberos F, Roig R. Influence of volume reduction and cryopresrvation methodologies on quality of thawed umbilical cord blood units for transplantation. Cryobiology. 2008;56:152–8.
Minegishi M, Itoh T, Fukawa N, Kitaura T, Miura J, Takahashi H, et al. Quality of umbilical cord blood CD34+ cells in a double-compartment freezing bag cryopreserved without a rate-controlled programmed freezer. Int J Hematol. 2007;85:78–84.
Beshlawy AE, Metwally HG, Khalek KA, Hammoud RF, Mousa SM. The effect of freezing on the recovery and expansion of umbilical cord blood hematopoietic stem cells. Exp Clin Transplant. 2009;7:50–5.
Meyer TP, Hofmann B, Zaisserer J, Jacobs VR, Fuchs B, Rapp S, et al. Analysis and cryopreservation of hematopoietic stem and progenitor cells from umbilical cord blood. Cytotherapy. 2006;8:265–76.
Solves P, Mirabet V, Carbonell-Uberos F, Soler A. CD34+ cell content before freezing represents the hematopoietic stem cell content of thawed and washed cord blood units. Transfusion. 2005;45:116–7.
Koliakos G, Alamdari DH, Tsagias N, Kouzi-Koliakos K, Michaloudi E, Karagiannis V. A novel high-yield volume-reduction method for the cryopreservation of UC blood units. Cytotherapy. 2007;9:654–9.
Harris DT, Schumacher MJ, Rychlik S, Booth A, Acevedo A, Rubinstein P, et al. Collection, separation and cryopreservation of umbilical cord blood for use in transplantation. Bone Marrow Transplant. 1994;13:135–43.
Broxmeyer HE, Cooper S. High-efficiency recovery of immature haematopoietic progenitor cells with extensive proliferative capacity from human cord blood cryopreserved for 10 years. Clin Exp Immunol. 1997;107:45–53.
Kobylka P, Ivanyi P, Breur-Vriesendorp BS. Preservation of immunological and colony-forming capacities of long-term (15 years) cryopreserved cord blood cells. Transplantation. 1998;65:1275–8.
Mugishima H, Harada K, Chin M, Suzuki T, Takagi K, Hayakawa S, et al. Effects of long-term cryopreservation on hematopoietic progenitor cells in umbilical cord blood. Bone Marrow Transplant. 1999;23:395–6.
Broxmeyer HE, Srour EF, Hangoc G, Cooper S, Anderson SA, Bodine DM. High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years. Proc Natl Acad Sci USA. 2003;100:645–50.
Hao QL, Shah AJ, Thiemann FT, Smogorzewska EM, Crooks GM. A functional comparison of CD34+ CD38− cells in cord blood and bone marrow. Blood. 1995;86:3745–53.
Huang S, Terstappen LW. Lymphoid and myeloid differentiation of single human CD34+, HLA-DR+, CD38− hematopoietic stem cells. Blood. 1994;83:1515–26.
Hao QL, Smogorzewska EM, Barsky LW, Crooks GM. In vitro identification of single CD34+ CD38− cells with both lymphoid and myeloid potential. Blood. 1998;91:4145–51.
Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, Arenzana-Seisdedos F, et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusion and prevents infection by T-cell-line-adapted HIV-1. Nature. 1996;382:833–5.
Peled A, Petit I, Kollet O, Magid M, Ponomaryov T, Byk T, et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science. 1999;283:845–8.
Rubinstein P, Dobria L, Rosenfield RE, Adamson JW, Migliaccio G, Migliaccio AR, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA. 1995;92:10119–22.
Keeney M, Chin-Yee I, Weir K, Popma J, Nayar R, Sutherland DR. Single platform flow cytometric absolute CD34+ cell counts based on ISHAGE guidelines. Cytometry. 1998;34:61–70.
Kurtberg J, Cario MS, Fraser JK, Baxter-Lowe L, Cohen G, Carter SL, et al. Results of the cord blood transplantation (COBLT) study unrelated donor banking program. Transfusion. 2005;45:842–55.
Migliaccio AR, Adamson JW, Stevens CE, Dobrila NL, Carrier CM, Rubinstein P. Cell dose and speed of engraftment in placenta/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood. 2000;96:2717–22.
Nagamura-Inoue T, Shioya M, Sugo M, Cui Y, Takahashi A, Tomita S, et al. Wash-out of DMSO dose not improve the speed of engraftment of cord blood transplantation: follow-up of 46 adults patients with units shipped from a single cord blood bank. Transfusion. 2003;43:1285–94.
Isoyama K, Oda M, Kato K, Nagamura-Inoue T, Kai S, Kigasawa H, et al. Long-term outcome of cord blood transplantation from unrelated donors as an initial transplantation procedure for children with AML in Japan. Bone Marrow Transplant. 2010;45:69–77.
Ogawa A, Takahashi M. Hematopoietic cell counting of cryopreserved cord blood before transplantaiton (in Japanese). Ketsueki Shuyouka. 2005;51:127–32.
Yoo KH, Lee SH, Kim HJ, Sung KW, Jung HL, Cho EJ, et al. The impact of post-thaw colony-forming units-granulocyte/macrophage on engraftment following unrelated cord blood transplantation in pediatric recipients. Bone Marrow Transplant. 2007;39:512–21.
Schmid I, Hausner MA, Cole SW, Uittenbogaart CH, Giorgi JV, Jamieson BD. Simultaneous flow cytometric measurement of viability and lymphocyte subset proliferation. J Immunol Methods. 2001;247:175–86.
Humpe A, Beck C, Schoch R, Kneba M, Horst HA. Establishment and optimization of a flow cytometric method for evaluation of viability of CD34+ cells after cryopreservation and comparison with trypan blue exclusion staining. Transfusion. 2005;45:1208–13.
Terstappen LW, Huang S, Safford M, Lansdorp PM, Loken MR. Sequential generations of hematopoietic colonies derived from single non-lineage committees CD34+ CD38− progenitor cells. Blood. 1991;77:1218–27.
Bhatia M, Wang JC, Kapp U, Bonnet D, Dick JE. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci USA. 1997;94:5320–5.
Timeus F, Crescenzio N, Basso G, Ramenghi U, Saracco P, Gabutti V. Cell adhesion molecule expression in cord blood CD34+ cells. Stem Cells. 1998;16:120–6.
Tashiro K, Tada H, Heilker R, Shirozu M, Nakano T, Honjyo T. Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science. 1993;261:895–7.
Spencer A, Jackson J, Bauch-Brown C. Enumeration of bone marrow “homing” haemopoietic stem cells from G-CSF-mobilised normal donors and influence on engraftment following allogeneic transplantation. Bone Marrow Transplant. 2001;28:1019–22.
Dabusti M, Lanza F, Campioni D, Castagnari B, Tieghi A, et al. CXCR-4 expression on bone marrow CD34+ cells prior to mobilization can predict mobilization adequacy in patients with hematologic malignancies. J Hematother Stem Cell Res. 2003;12:425–34.
Acknowledgments
This study was supported in part by a research grant on Tissue Engineering (H17-014) and a research grant on Allergic Disease and Immunology (H20-015) from the Japanese Ministry of Health, Labour and Welfare. We thank all the members of Kanagawa Cord Blood Bank their valuable support and assistance. We also acknowledge the excellent technical support of Ms. Ayumi Ogata and Mr. Takao Suzuki in conducting this study.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Yamamoto, S., Ikeda, H., Toyama, D. et al. Quality of long-term cryopreserved umbilical cord blood units for hematopoietic cell transplantation. Int J Hematol 93, 99–105 (2011). https://doi.org/10.1007/s12185-010-0755-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-010-0755-x